Implementing iRisk for Effective Knowledge and Risk Management at Boehringer Ingelheim

See All 2024 Sessions

Implementing iRisk for Effective Knowledge and Risk Management at Boehringer Ingelheim

Susanne Weiler

Senior Risk Manager, Pharmaceutical Development Biologicals

Boehringer Ingelheim

Profile

See BI's step-by-step approach for the implementation of iRisk in Development Biologicals for the end-to-end process from CQA assessment over different types of Risk Assessments to Control Strategy Summary.

More About Quality Risk Management

Digitalizing Pharma Control Strategies: A Roadmap

Transform pharma manufacturing with digital control strategies. Learn how to enhance product quality, streamline processes, and ensure regulatory compliance.

Let's Move Beyond Spreadsheets for Risk Management

Discover why Excel is no longer sufficient for effective risk management in the pharma industry and why transitioning to specialized software is crucial.

Build an Effective Data Integrity Program with Risk Management

Understand why data integrity problems occur, and learn how to build an effective, risk-based corporate data integrity program to address them.